about
Population pharmacokinetics of piperacillin continuous infusion in critically ill patients.Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational studyEmergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU: Intermittent versus continuous infusion. A retrospective cohort studyMeasuring antibiotics in exhaled air in critically ill, non-ventilated patients: A feasibility and proof of concept studyAntimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sofie A.M. Dhaese
@ast
Sofie A.M. Dhaese
@en
Sofie A.M. Dhaese
@es
Sofie A.M. Dhaese
@nl
type
label
Sofie A.M. Dhaese
@ast
Sofie A.M. Dhaese
@en
Sofie A.M. Dhaese
@es
Sofie A.M. Dhaese
@nl
prefLabel
Sofie A.M. Dhaese
@ast
Sofie A.M. Dhaese
@en
Sofie A.M. Dhaese
@es
Sofie A.M. Dhaese
@nl
P106
P21
P31
P496
0000-0002-2252-7167